Balyasny Asset Management’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
Balyasny Asset Management's ASTH Position: Q2 2026 in Review
Balyasny Asset Management sold out of Astrana Health (ASTH) in Q2 2026, closing a stake of 58,448 shares — an estimated $1.43M sold.
Balyasny Asset Management first reported a position in ASTH in Q2 2021 and held it in 13 quarters. The position peaked at $2.83M in Q4 2025. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Balyasny Asset Management reported no remaining Astrana Health position as of Q2 2026 after selling out during the quarter.
- Balyasny Asset Management sold 58,448 Astrana Health shares in Q2 2026, an estimated $1.43M.
- Balyasny Asset Management first reported a position in Astrana Health in Q2 2021 and held it in 13 quarters.
- Balyasny Asset Management's Astrana Health position peaked at $2.83M in Q4 2025.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.